CA Patent

CA2778194C — 2-oxo-1-pyrrolidinyl imidazothiadiazole derivatives

Assigned to UCB Biopharma SRL · Expires 2016-07-12 · 10y expired

What this patent protects

The present invention relates to 2-oxo-1-pyrrolidine imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.

USPTO Abstract

The present invention relates to 2-oxo-1-pyrrolidine imidazothiadiazole derivatives, processes for preparing them, pharmaceutical compositions containing them and their use as pharmaceuticals.

Drugs covered by this patent

Patent Metadata

Patent number
CA2778194C
Jurisdiction
CA
Classification
—
Expires
2016-07-12
Drug substance claim
No
Drug product claim
No
Assignee
UCB Biopharma SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.